Upstream Bio develops verekitug, an experimental antibody drug for severe asthma, nasal polyps and COPD. It last closed at $1.59 on Nov 20, down 20.50% on the day. The next earnings report for UPB is expected around Wed, Feb 10, 2027. For the quarter ended Sep 2026, UPB reported EPS of -$0.75 on revenue of $395,000, with revenue down 42.2% from a year ago. Over its last 8 reports the stock moved an average of 10.4% the session after earnings. Over the last 12 months UPB insiders bought $0 of stock on the open market and sold $105K, according to SEC Form 4 filings.
AI Auto Pilots
Is UPB in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold UPB.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on UPBStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
UPB · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 82% below its 20 day and 142% below its 50 day average. It is 353% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 23), oversold. The nearest support is the 52 week low at $1.56, and the nearest resistance the Pivot at $1.74.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 21.9%/day
Key levels
$33.6852 week high+2018.2%
$7.20200 day average+352.8%
$5.34100 day average+235.8%
$3.8450 day average+141.5%
$3.84Swing high (Nov 4)+141.5%
$2.8920 day average+81.8%
$1.91Pivot R1+20.1%
$1.74Pivot+9.4%
$1.59Last close
$1.5652 week low−1.9%
$1.41Pivot S1−11.3%
Indicators
RSI (14)
22.77
Oversold below 30
Oversold
MACD
-0.52
Below its signal line
Bearish
Stochastic
1.8
Near the bottom of its range
Oversold
ADX (14)
39.0
Trending down
Williams %R
-98.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-174.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−50.8%
Change over 10 sessions
Bearish
ATR (14)
$0.35
Typical daily range, 21.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityHigh, 70.4%/day
Key levels
$33.6852 week high+2018.2%
$7.20200 day average+352.8%
$5.34100 day average+235.8%
$3.8450 day average+141.5%
$3.84Swing high (Nov 4)+141.5%
$2.8920 day average+81.8%
$1.91Pivot R1+20.1%
$1.74Pivot+9.4%
$1.59Last close
$1.5652 week low−1.9%
$1.41Pivot S1−11.3%
Indicators
RSI (14)
23.22
Oversold below 30
Oversold
MACD
-2.05
Below its signal line
Bearish
Stochastic
4.5
Near the bottom of its range
Oversold
ADX (14)
35.8
Trending down
Williams %R
-99.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-149.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−72.3%
Change over 10 sessions
Bearish
ATR (14)
$1.12
Typical daily range, 70.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for UPB
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how UPB did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for UPBHow many large options trades hit UPB, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in UPB in the last 90 days.
From SEC Form 4 filings by UPB's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether UPB is in one of them and how their past UPB trades turned out.
Upstream Bio is a biotechnology company based in Waltham, Massachusetts, that develops treatments for inflammatory diseases. Its main candidate, verekitug, is a monoclonal antibody that blocks the receptor for a protein called TSLP, which plays a role in immune responses. The company is testing verekitug in clinical trials for severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease. The drug is not yet approved, and its intended patients are people with these lung and airway conditions.